NovoCure Limited
NVCR
$15.21
$3.2827.49%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -24.50M | -37.27M | -40.14M | -34.32M | -65.92M |
| Total Depreciation and Amortization | 2.70M | 3.66M | 3.44M | 3.33M | 1.74M |
| Total Amortization of Deferred Charges | 5.15M | -- | -- | -- | 5.14M |
| Total Other Non-Cash Items | 13.93M | 24.83M | 27.40M | 22.84M | 50.99M |
| Change in Net Operating Assets | -15.28M | 29.35M | -6.64M | -27.51M | 4.61M |
| Cash from Operations | -18.00M | 20.57M | -15.94M | -35.67M | -3.45M |
| Capital Expenditure | -4.90M | -5.66M | -5.49M | -10.61M | -8.94M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 341.22M | 77.09M | 41.47M | 4.14M | -13.27M |
| Cash from Investing | 336.33M | 71.44M | 35.99M | -6.47M | -22.21M |
| Total Debt Issued | 0.00 | 99.98M | -- | -- | 0.00 |
| Total Debt Repaid | -560.95M | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 1.60M | 538.00K | 2.39M | 5.25M | 2.69M |
| Repurchase of Common Stock | -146.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -559.49M | 100.52M | 2.39M | 5.25M | 2.69M |
| Foreign Exchange rate Adjustments | -76.00K | -22.00K | 265.00K | 227.00K | -128.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -241.25M | 192.51M | 22.70M | -36.66M | -23.11M |